Literature DB >> 1361223

Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease.

Y Iwasaki1, K Ikeda, T Shiojima, M Kinoshita.   

Abstract

We measured fasting plasma amino acids in 20 patients with Parkinson's disease (PD) and 20 controls matched for age and sex. PD patients had significant elevations in plasma levels of aspartate, glutamate and glycine. The levels of other amino acids were not significantly different from those found in controls. No correlation was noted between PD severity and the degree of abnormality of plasma amino acids. We conclude that excitatory amino acids may be altered in patients with PD, and raise the possibility that neuroexcitotoxic mechanisms may be involved in the neurodegeneration of PD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361223     DOI: 10.1016/0304-3940(92)90015-y

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Authors:  S Engelborghs; B Marescau; P P De Deyn
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

Review 2.  The discovery of human of GLUD2 glutamate dehydrogenase and its implications for cell function in health and disease.

Authors:  Pullanipally Shashidharan; Andreas Plaitakis
Journal:  Neurochem Res       Date:  2013-12-19       Impact factor: 3.996

3.  Sodium Benzoate, a Metabolite of Cinnamon and a Food Additive, Upregulates Ciliary Neurotrophic Factor in Astrocytes and Oligodendrocytes.

Authors:  Khushbu K Modi; Malabendu Jana; Susanta Mondal; Kalipada Pahan
Journal:  Neurochem Res       Date:  2015-09-23       Impact factor: 3.996

4.  Metabolomics of blood reveals age-dependent pathways in Parkinson's Disease.

Authors:  Nicola D'Ascenzo; Emanuele Antonecchia; Antonella Angiolillo; Victor Bender; Marco Camerlenghi; Qingguo Xie; Alfonso Di Costanzo
Journal:  Cell Biosci       Date:  2022-07-06       Impact factor: 9.584

5.  Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease.

Authors:  Ludovica Iovino; Veronica Giusti; Francesca Pischedda; Elena Giusto; Nicoletta Plotegher; Antonella Marte; Ilaria Battisti; Angela Di Iacovo; Algerta Marku; Giovanni Piccoli; Rina Bandopadhyay; Carla Perego; Tiziana Bonifacino; Giambattista Bonanno; Cristina Roseti; Elena Bossi; Giorgio Arrigoni; Luigi Bubacco; Elisa Greggio; Sabine Hilfiker; Laura Civiero
Journal:  Acta Neuropathol       Date:  2022-05-21       Impact factor: 15.887

6.  A glutamate-dependent redox system in blood cells is integral for phagocytosis in Drosophila melanogaster.

Authors:  Jessica Tang; Ashley E Nazario-Toole; Elizabeth A Gonzalez; Aprajita Garg; Louisa P Wu
Journal:  Curr Biol       Date:  2013-11-07       Impact factor: 10.834

7.  Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection.

Authors:  Shiek Ssj Ahmed; Winkins Santosh; Suresh Kumar; Hema T Thanka Christlet
Journal:  J Biomed Sci       Date:  2009-07-13       Impact factor: 8.410

8.  Up-regulation of neurotrophic factors by cinnamon and its metabolite sodium benzoate: therapeutic implications for neurodegenerative disorders.

Authors:  Arundhati Jana; Khushbu K Modi; Avik Roy; John A Anderson; Richard B van Breemen; Kalipada Pahan
Journal:  J Neuroimmune Pharmacol       Date:  2013-03-09       Impact factor: 4.147

9.  Correlations between plasma levels of amino acids and nonmotor symptoms in Parkinson's disease.

Authors:  Qing Tong; Qinrong Xu; Qiang Xia; Yongsheng Yuan; Li Zhang; Hongbin Sun; Han Shan; Kezhong Zhang
Journal:  J Neural Transm (Vienna)       Date:  2014-07-25       Impact factor: 3.575

10.  Gain-of-function variant in GLUD2 glutamate dehydrogenase modifies Parkinson's disease onset.

Authors:  Andreas Plaitakis; Helen Latsoudis; Konstantinos Kanavouras; Beate Ritz; Jeff M Bronstein; Irene Skoula; Vasileios Mastorodemos; Spyridon Papapetropoulos; Nikolas Borompokas; Ioannis Zaganas; Georgia Xiromerisiou; George M Hadjigeorgiou; Cleanthe Spanaki
Journal:  Eur J Hum Genet       Date:  2009-10-14       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.